Histamine H₃Receptor as a Drug Discovery Target

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTHistamine H3 Receptor as a Drug Discovery TargetMichael Berlin*, Christopher W. Boyce, and Manuel de Lera RuizView Author Information Chemical Research, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States *To whom correspondence should be addressed. Phone: 1-908-740-3909. Fax: 1-908-740-7152. E-mail: [email protected]Cite this: J. Med. Chem. 2011, 54, 1, 26–53Publication Date (Web):November 9, 2010Publication History Received15 January 2010Published online9 November 2010Published inissue 13 January 2011https://pubs.acs.org/doi/10.1021/jm100064dhttps://doi.org/10.1021/jm100064dreview-articleACS PublicationsCopyright © 2010 American Chemical SocietyRequest reuse permissionsArticle Views6147Altmetric-Citations124LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Agonists,Amines,Antagonists,Receptors,Rodent models Get e-Alerts